Last update July 10, 2017
Limited compatibility
We do not have alternatives for チザニジン塩酸塩.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
チザニジン塩酸塩 is Tizanidine Hydrochloride in Japanese.
Is written in other languages:Main tradenames from several countries containing チザニジン塩酸塩 in its composition:
Variable | Value | Unit |
---|---|---|
Oral Bioavail. | 40 | % |
Molecular weight | 290 | daltons |
Protein Binding | 30 | % |
VD | 2.6 | l/Kg |
Tmax | 1 | hours |
T½ | 2 - 4 | hours |
Write us at elactancia.org@gmail.com
e-lactancia is a resource recommended by IHAN of Spain
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM
Centrally acting muscle relaxant.
Since the last update we have not found published data on its excretion in breast milk.
Its pharmacokinetic data: low molecular weight, high liposolubility (Acorda 2006), makes it probable that it could pass to milk in potentially significant quantities.
During breastfeeding, it seems prudent to avoid it (Hutchinson 2013) or to use it very sporadically and limited to sufficient minimum doses, monitoring for possible sedation of the infant, especially during the first 3 months of life.